Grifols (GRFS) Operating Leases (2019 - 2025)

Grifols (GRFS) reported Operating Leases of $1.1 billion for Q4 2025, up 2.98% on a YoY basis from $1.1 billion in Q4 2024, and up 2.98% quarter-over-quarter from $1.1 billion in Q4 2024.

Grifols (GRFS) Operating Leases (2019 - 2025) Analysis & Trends

Grifols has reported Operating Leases for 7 years, with the latest figure at $1.1 billion in Q4 2025.

  • For the quarter ending Q4 2025, Operating Leases rose 2.98% year-over-year to $1.1 billion; the trailing twelve-month figure through Dec 2025 stood at $1.1 billion (up 2.98% YoY), and the FY2025 full-year result was $1.1 billion, up 2.98% from the prior year.
  • Operating Leases for Q4 2025 stood at $1.1 billion, up from $1.1 billion in the prior quarter.
  • The five-year high for Operating Leases was $1.1 billion in Q4 2025, with the low at $933.1 million in Q4 2022.
  • Historically, Operating Leases has averaged $1.0 billion across 5 years, with a median of $1.1 billion in 2023.
  • Annual changes were most pronounced in 2022 — Operating Leases declined 1.15% — and 2023, when it gained 15.79%.
  • Grifols' Operating Leases stood at $944.0 million in 2021, then dropped by 1.15% to $933.1 million in 2022, then climbed by 15.79% to $1.1 billion in 2023, then advanced by 1.37% to $1.1 billion in 2024, then rose by 2.98% to $1.1 billion in 2025.
  • The last three Operating Leases figures came in at $1.1 billion (Q4 2025), $1.1 billion (Q4 2024), and $1.1 billion (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Grifols 6.05 Bn 5.09 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2025 1.13 Bn
Dec 31, 2024 1.10 Bn
Dec 31, 2023 1.08 Bn
Dec 31, 2022 933.11 Mn
Dec 31, 2021 943.96 Mn
Dec 31, 2020 823.70 Mn
Dec 31, 2019 770.71 Mn